Temple University Of The Commonwealth System Of Higher Education
发明人:
申请号：
EP15743948.0
公开号：
EP3099333A4
申请日:
2015.01.30
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.
